Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Invested Capital: 2009-2025

Historic Invested Capital for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $131.8 million.

  • Lifecore Biomedical's Invested Capital fell 3.10% to $131.8 million in Q2 2025 from the same period last year, while for May 2025 it was $131.8 million, marking a year-over-year decrease of 3.10%. This contributed to the annual value of $131.8 million for FY2025, which is 3.10% down from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's Invested Capital is $131.8 million, which was down 3.10% from $136.0 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Invested Capital ranged from a high of $366.8 million in FY2021 and a low of $80.6 million during FY2023.
  • Its 3-year average for Invested Capital is $116.1 million, with a median of $131.8 million in 2025.
  • As far as peak fluctuations go, Lifecore Biomedical's Invested Capital slumped by 56.66% in 2023, and later spiked by 68.70% in 2024.
  • Over the past 5 years, Lifecore Biomedical's Invested Capital (Yearly) stood at $366.8 million in 2021, then slumped by 49.30% to $186.0 million in 2022, then plummeted by 56.66% to $80.6 million in 2023, then spiked by 68.70% to $136.0 million in 2024, then fell by 3.10% to $131.8 million in 2025.